[1]
“The Pharmacoeconomic Analysis of the Treatment Regimens of Patients Having Cardiovascular Diseases with Drugs of the Antithrombotic Action”, AJP, vol. 13, no. 3, Jul. 2019, doi: 10.22377/ajp.v13i3.3290.